Browse 5 pharmaceutical patents cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.
Settlement Agreement Unenforceable Due to Lack of Mutual Assent
Colage v. Collins, decided by Federal Circuit on December 3, 2025, resulted in a defendant win outcome. The case concerns the enforceability of a settlement agreement in a patent infringement dispute....
Federal Circuit Affirms Patent Invalidity for Erectile Dysfunction Drug
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on September 23, 2025, resulted in a defendant win outcome. The core dispute involved the validity of a patent...
CAFC Affirms Obviousness Finding, Invalidating MS Drug Patent
Acorda Therapeutics, Inc. v. Alkermes Plc, decided by Federal Circuit on July 25, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the district court's grant of summary judgment...
Federal Circuit Affirms Patent Infringement for Schizophrenia Treatment
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., decided by Federal Circuit on July 8, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Teva Pharmaceutic...
Federal Circuit Upholds Merck's Januvia Patent Against Obviousness Challenge
Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc., decided by Federal Circuit on March 13, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck's patent for its b...
CaseLawBrief currently tracks 5 pharmaceutical patents cases from Federal Circuit. This number is updated as new opinions are published.
Outcome breakdown: Defendant Win: 4, Plaintiff Win: 1.
Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.